Calli M. Lear-Rooney

1.5k total citations · 1 hit paper
8 papers, 1.0k citations indexed

About

Calli M. Lear-Rooney is a scholar working on Infectious Diseases, Molecular Biology and Sociology and Political Science. According to data from OpenAlex, Calli M. Lear-Rooney has authored 8 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 1 paper in Molecular Biology and 1 paper in Sociology and Political Science. Recurrent topics in Calli M. Lear-Rooney's work include Viral Infections and Outbreaks Research (7 papers), Viral Infections and Vectors (6 papers) and Viral gastroenteritis research and epidemiology (2 papers). Calli M. Lear-Rooney is often cited by papers focused on Viral Infections and Outbreaks Research (7 papers), Viral Infections and Vectors (6 papers) and Viral gastroenteritis research and epidemiology (2 papers). Calli M. Lear-Rooney collaborates with scholars based in United States and United Kingdom. Calli M. Lear-Rooney's co-authors include Gene G. Olinger, Lisa M. Johansen, Pamela J. Glass, Lisa E. Hensley, Reed F. Johnson, Brit J. Hart, Jason Kindrachuk, Michael R. Holbrook, Julie Dyall and Thiagarajan Venkataraman and has published in prestigious journals such as Journal of Virology, Antimicrobial Agents and Chemotherapy and Science Translational Medicine.

In The Last Decade

Calli M. Lear-Rooney

8 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

2014 475 citations Julie Dyall, Christopher M. Coleman et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Calli M. Lear-Rooney United States	8	707	229	223	129	94	8	1.0k
Melissa M. Coughlin United States	12	768 1.1×	276 1.2×	141 0.6×	242 1.9×	143 1.5×	27	1.2k
David Shum South Korea	16	504 0.7×	338 1.5×	204 0.9×	168 1.3×	109 1.2×	44	1.1k
Ulrik Fahnøe Denmark	17	494 0.7×	184 0.8×	303 1.4×	109 0.8×	71 0.8×	71	1.0k
Ana Shulla United States	8	581 0.8×	314 1.4×	147 0.7×	82 0.6×	120 1.3×	8	1.0k
Gregory R. Bluemling United States	10	663 0.9×	179 0.8×	320 1.4×	56 0.4×	47 0.5×	15	901
Jeong-Joong Yoon United States	16	455 0.6×	180 0.8×	434 1.9×	52 0.4×	84 0.9×	22	912
Chonsaeng Kim South Korea	18	284 0.4×	315 1.4×	175 0.8×	51 0.4×	111 1.2×	30	729
Cary Retterer United States	16	863 1.2×	224 1.0×	359 1.6×	44 0.3×	146 1.6×	24	1.3k
Natacha S. Ogando Netherlands	12	778 1.1×	403 1.8×	96 0.4×	91 0.7×	91 1.0×	22	1.1k

Countries citing papers authored by Calli M. Lear-Rooney

Since Specialization

Citations

This map shows the geographic impact of Calli M. Lear-Rooney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calli M. Lear-Rooney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calli M. Lear-Rooney more than expected).

Fields of papers citing papers by Calli M. Lear-Rooney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calli M. Lear-Rooney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calli M. Lear-Rooney. The network helps show where Calli M. Lear-Rooney may publish in the future.

Co-authorship network of co-authors of Calli M. Lear-Rooney

This figure shows the co-authorship network connecting the top 25 collaborators of Calli M. Lear-Rooney. A scholar is included among the top collaborators of Calli M. Lear-Rooney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calli M. Lear-Rooney. Calli M. Lear-Rooney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Wang, Minxiu, et al.. (2015). Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry. Journal of Virology. 89(10). 5441–5449. 49 indexed citations

2.

Keck, Zhen–Yong, Sven Enterlein, Katie A. Howell, et al.. (2015). Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein. Journal of Virology. 90(1). 279–291. 63 indexed citations

3.

Cheng, Han, Calli M. Lear-Rooney, Lisa M. Johansen, et al.. (2015). Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists. Journal of Virology. 89(19). 9932–9938. 87 indexed citations

4.

Johansen, Lisa M., Lisa Evans DeWald, Charles J. Shoemaker, et al.. (2015). Supplementary Materials for A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity. 8 indexed citations

5.

Johansen, Lisa M., Lisa Evans DeWald, Charles J. Shoemaker, et al.. (2015). A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity. Science Translational Medicine. 7(290). 290ra89–290ra89. 180 indexed citations

6.

Garrison, Aura R., Barbara Giomarelli, Calli M. Lear-Rooney, et al.. (2014). The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus. Antiviral Research. 112. 1–7. 72 indexed citations

7.

Dyall, Julie, Christopher M. Coleman, Brit J. Hart, et al.. (2014). Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection. Antimicrobial Agents and Chemotherapy. 58(8). 4885–4893. 475 indexed citations breakdown →

8.

Smither, Sophie J., et al.. (2013). Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity. Journal of Virological Methods. 193(2). 565–571. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact